Intermediate Size Expanded Access Protocol Using Autologous HB-adMSCs for the Treatment of Parkinson's Disease

NCT06056427 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

BIOLOGICAL: HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)

Sponsor

Hope Biosciences Research Foundation